HDAC inhibitor Tacedinaline, Purity ≥98%

Synonym: 112522-64-2; Tacedinaline; ci-994; 4-Acetamido-N-(2-Aminophenyl)benzamide; Acetyldinaline; CI 994; 4-Acetylamino-N-(2'-aminophenyl)benzamide; HDAC inhibitor

MDL: MFCD00866266
CAS Number: 112522-64-2
Compound CID: 2746

Product Size

10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Tacedinaline, soluble in DMSO and insoluble in ethanol and water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC1, HDAC2, and HDAC3.

Molecular Weight

269.3

Molecular Formula

C₁₅H₁₅N₃O₂

Targets

HDAC1: 0.9 μM; HDAC2: 0.9 μM; HDAC3: 1.2 μM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 51 mg/mL (189.37 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Tacedinaline is used in research to explore its role in inhibiting histone deacetylase (HDAC) and its therapeutic potential in the treatment of cancer.

Storage

Store at -20ºC.